Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT)
NCT00889590
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
15
Enrollment
OTHER
Sponsor class
Stopped
low recruitment with registration denosumab
Conditions
Giant Cell Tumor of Bone
Osteoclastoma
Interventions
DRUG:
Zoledronic acid
Sponsor
Leiden University Medical Center